Epstein-Barr virus reactivation occurs when a dormant viral infection comes back to life, potentially triggering a range of troubling symptoms that can persist for weeks or even months, affecting people who thought they had left the virus behind years ago.
Understanding Epstein-Barr Virus Reactivation
Epstein-Barr virus (EBV) is one of the most widespread viral infections across the globe. This virus, which belongs to the herpesvirus family (a group of viruses that can remain in the body for life), affects an enormous portion of the population. In the United States alone, approximately 50% of children up to age 5 and about 95% of adults have been infected with EBV at some point in their lives.[2] Worldwide, infection rates reach 90% or more of the population, making EBV remarkably common.[3]
What makes EBV particularly challenging is its behavior after the initial infection. Unlike many viruses that the immune system can completely eliminate, EBV never truly leaves the body. Instead, once you become infected, the virus establishes what doctors call a latent or dormant state, hiding quietly inside certain immune cells called B lymphocytes (a type of white blood cell that normally helps fight infections).[2] In most people, the virus remains inactive for their entire lifetime without causing problems. However, under certain circumstances, the sleeping virus can wake up and become active again—a process known as reactivation.
During reactivation, the virus can begin multiplying again and potentially cause symptoms, although many people who experience reactivation may not develop obvious signs of illness. When the immune system is functioning normally, specialized immune cells called CD4+ T cells keep the virus under control.[5] These cells act like security guards, constantly monitoring the body and preventing the virus from becoming active. When something weakens or distracts the immune system, however, EBV can seize the opportunity to reactivate.
Epidemiology
The initial infection with Epstein-Barr virus typically occurs during childhood or adolescence. When young children first encounter the virus, they usually experience no symptoms or only mild, brief illness that resembles a common cold or flu—symptoms so ordinary that parents and doctors might not recognize it as EBV.[2] By the time children reach 5 years of age in the United States, approximately half have already been infected, though most families never knew it happened.[2]
The picture changes dramatically when the first infection happens during the teenage years or young adulthood. In adolescents and adults, EBV commonly causes infectious mononucleosis, often called “mono” or the “kissing disease” because it spreads through saliva.[1][3] This illness is most frequently seen in teenagers and young adults, who are more likely to share drinks or engage in kissing, facilitating transmission of the virus.
Chronic active Epstein-Barr virus (CAEBV), a severe form where the virus causes ongoing illness, is quite rare in the United States and Europe but occurs more frequently in Asia and South America.[6] This geographical pattern suggests that genetic, environmental, or viral strain differences may influence who develops more serious complications from EBV infection.
Causes and Transmission
Epstein-Barr virus spreads primarily through close person-to-person contact, with saliva being the main route of transmission. The virus is highly contagious and can pass from one person to another in several ways. Kissing is one of the most common methods of spread, which explains why infectious mononucleosis earned its nickname as the “kissing disease.”[2] However, kissing is far from the only way EBV spreads.
Sharing eating utensils, drinking glasses, plates, or toothbrushes with someone who has EBV can transmit the virus.[1][2] Young children can spread the virus by putting toys in their mouths or drooling on objects that others then touch. Coughing and sneezing can also spread infected saliva droplets through the air. Beyond saliva, EBV can be transmitted through other body fluids including blood and semen, meaning sexual contact, blood transfusions, and organ transplants can also spread the virus.[2]
One particularly concerning aspect of EBV transmission is that infected individuals can spread the virus to others even when they have no symptoms.[1][2] The virus can be contagious during the incubation period (the time between when someone gets infected and when symptoms appear), which typically lasts four to six weeks.[2] This means people can unknowingly pass the virus to family members, friends, or romantic partners before they even realize they are sick. Additionally, when the virus reactivates in someone who was infected years earlier, they may again become contagious and spread the virus to others, even if they experience no symptoms during the reactivation.
Risk Factors for Reactivation
While most people infected with EBV will carry the dormant virus without problems, certain factors can trigger reactivation. Understanding these risk factors is important because some of them can be modified or managed to reduce the likelihood of the virus waking up.
Stress is one of the primary triggers for EBV reactivation. Both psychological stress (emotional or mental strain) and cellular stress (physical strain on the body’s cells) can disturb the delicate balance between the immune system and the dormant virus.[3] When the body experiences significant stress, it affects immune function, potentially weakening the surveillance system that keeps EBV suppressed.[2]
A weakened immune system represents perhaps the most significant risk factor for EBV reactivation. People with compromised immune systems due to cancer, HIV/AIDS, or conditions requiring immunosuppressant medications (drugs that deliberately reduce immune system activity, often given after organ transplants or for autoimmune diseases) face a higher risk of reactivation.[1][2] Those with chronic fatigue syndrome or other ongoing illnesses may also be more susceptible because their immune systems are constantly activated and may become overtaxed.
Hormonal changes also play a role in EBV reactivation. Menopause, when a woman’s body undergoes significant hormonal shifts, has been identified as a potential trigger for the virus to become active again.[1][2] Other hormonal imbalances caused by various health conditions, medications, or life stages may similarly affect immune function and increase reactivation risk.
Recent research has documented a connection between COVID-19 infection and EBV reactivation. Studies show that acute COVID-19 can trigger near-immediate reactivation of EBV, while other cases show EBV reactivation occurring several months after COVID-19 infection.[11] This connection appears to be related to how COVID-19 affects the immune system, potentially creating conditions favorable for dormant viruses to reactivate.
Symptoms of EBV Reactivation
When Epstein-Barr virus reactivates, many people experience no symptoms at all. However, those with weakened immune systems or certain health conditions are more likely to develop symptoms similar to those experienced during the initial infection.[1] Recognizing these symptoms can be challenging because they often resemble other common illnesses.
Extreme fatigue stands out as one of the most prominent and debilitating symptoms of EBV reactivation. This is not ordinary tiredness that improves with rest; rather, it is profound, chronic exhaustion that can persist for weeks or months.[1] People describe feeling completely drained of energy, unable to perform normal daily activities, and sometimes unable to get out of bed. This fatigue often accompanies what is known as chronic fatigue syndrome in some individuals.
Other common symptoms of EBV reactivation include a sore throat and throat inflammation (swelling and irritation of the throat tissues), which can make swallowing uncomfortable. Swollen tonsils may be visible at the back of the throat.[1] Many people develop fever, though this is more typical of acute infection than reactivation. Headaches can range from mild to severe and may persist alongside other symptoms.
Physical examination during reactivation often reveals swollen lymph nodes, particularly in the neck. These bean-shaped organs, part of the immune system, become enlarged as they work to fight the viral activity.[1][2] The spleen and liver may also become enlarged, conditions known as splenomegaly (abnormally large spleen) and hepatomegaly (abnormally large liver). An enlarged spleen is particularly concerning because it becomes more fragile and susceptible to rupture from physical trauma.
Skin rashes can appear in some individuals during EBV reactivation. The rash may vary in appearance and location on the body.[1][2] Additional symptoms may include severe body aches, chronic joint pain, and chronic muscle pain. Some people experience liver dysfunction, which blood tests can detect, and thrombocytopenia (abnormally low levels of platelets, the blood cells responsible for clotting).
The duration of symptoms typically ranges from two to four weeks, though fatigue and other effects can linger for several weeks or even months, particularly in adults and teenagers.[2] In rare cases, EBV infections and reactivations can last more than six months, qualifying as chronic active EBV disease.[1]
Prevention
Currently, no vaccine exists to protect against Epstein-Barr virus infection.[10] Scientists are working to develop effective vaccines, but none have been approved for use. This means prevention focuses primarily on reducing exposure to the virus and, for those already infected, minimizing the risk of reactivation.
For people who have not yet been infected with EBV, preventing initial infection involves avoiding contact with infected saliva and other body fluids. This means not sharing drinking glasses, eating utensils, water bottles, or food with others, especially during cold and flu season when viral illnesses are more common. Parents should avoid sharing toothbrushes with children and should teach children not to put toys that other children have mouthed into their own mouths. Avoiding kissing or intimate contact with people who have infectious mononucleosis or active EBV symptoms is also important.[10]
For the vast majority of people who already carry dormant EBV, prevention focuses on avoiding reactivation. Since stress is a major trigger, learning and practicing stress management techniques can be beneficial. This might include regular exercise, meditation, adequate sleep, journaling, or seeking mental health support when needed. Managing psychological stress helps maintain a stronger immune system, which in turn keeps the virus suppressed.
Maintaining overall immune health is crucial for preventing EBV reactivation. This involves getting adequate rest and sleep each night, as sleep is when the immune system does much of its maintenance and repair work. Staying well-hydrated supports all bodily functions, including immune responses. A nutritious, balanced diet provides the vitamins, minerals, and other nutrients the immune system needs to function properly. Some functional medicine approaches suggest that reducing sugar intake and following an anti-inflammatory diet, such as the Mediterranean diet, may help support immune function.
For people taking immunosuppressant medications or those with conditions that weaken immunity, working closely with healthcare providers to monitor health and address any signs of infection promptly becomes especially important. Regular medical check-ups can help identify problems early when they are easier to manage.
Pathophysiology
Understanding how Epstein-Barr virus affects the body helps explain why symptoms occur and why the virus is so difficult to eliminate. The virus has evolved sophisticated mechanisms to evade the immune system and establish lifelong residence in human cells.
When EBV first enters the body, it targets and infects B lymphocytes, a type of white blood cell that normally produces antibodies to fight infections.[2] These are the same cells that should be defending the body against invaders. By infecting these immune cells, the virus essentially hijacks part of the immune system for its own survival. Once inside B cells, the virus attaches to these cells and prevents them from functioning properly to fight the infection, which is why symptoms develop.[2]
After the acute infection phase, EBV does not simply remain quietly in one spot. Instead, it integrates itself into the B lymphocytes and establishes what scientists call latency. During latency, the virus essentially “goes to sleep,” producing few or no viral particles and expressing only limited viral genes. This stealth mode allows the virus to hide from the immune system, which is primarily designed to recognize and attack actively reproducing viruses. The infected B cells continue circulating through the bloodstream and lymphatic system, carrying the dormant virus with them.
The immune system does mount a response to control EBV. Specialized immune cells, particularly CD4+ T cells (a type of T lymphocyte that helps coordinate immune responses), work to keep the virus suppressed.[5] These cells constantly patrol the body, monitoring for signs of viral reactivation. Natural killer cells and other components of the immune system also participate in controlling EBV. In healthy individuals with robust immune function, this surveillance system successfully keeps the virus dormant indefinitely.
When the immune system becomes weakened or distracted, however, the balance shifts. Stress, illness, immunosuppressive medications, hormonal changes, or other factors can reduce the effectiveness of immune surveillance. When this happens, the dormant virus in B lymphocytes can reactivate, beginning to reproduce and potentially causing symptoms again. During reactivation, the virus may attack additional B lymphocytes, spreading to more cells.[5]
In cases of chronic active EBV, particularly in Asia and South America, the virus behaves somewhat differently. Rather than remaining primarily in B cells, it can infect T cells or natural killer (NK) cells.[6] When EBV infects these different cell types, the disease often follows a more aggressive course with different symptoms and potentially more serious complications. Patients with chronic active EBV frequently show elevated levels of various cytokines (chemical messengers that immune cells use to communicate), including both inflammatory and anti-inflammatory signals, indicating an immune system in chaos.[6]
The physical symptoms of EBV reactivation result from both direct viral effects and the immune system’s response to the active virus. Swollen lymph nodes, fever, and sore throat reflect the immune system mobilizing to fight the infection. Fatigue may result from the energy demands of the immune response as well as potential effects of cytokines on the brain and body. Enlargement of the spleen and liver occurs because these organs house many immune cells and become sites of intense immune activity during viral infections.